Should You Look To Invest In Private Banks? #AskBQ

Parthiv Shah: I am very bullish on this stock. I recommend you to hold on with a two-to-three year view. You can also cost average at the current price.

Amar Singh: One can buy at Rs 225-235 levels with a six-month view, with a stop-loss below Rs 200 and a target of Rs 265-275 levels on the upside.

Parthiv Shah: One can hold on to the stock with a long-term view.

Amar Singh: I would suggest waiting for the company’s quarterly results and then take a call.

Parthiv Shah: Hold on to the stock if you have bought shares through IPO. If not, I suggest not to enter the stock at current levels, since valuations look stretched.

Parthiv Shah: One can hold on to Sun Pharma as the stock is expected to touch 650-700 levels. Instead of Yes Bank, I would prefer RBL Bank and Federal Bank.

Amar Singh: I would recommend holding on to BEPL. The investor could book profit on 50 percent of holding and and hold on to the remaining shares with a stop-loss below Rs 180. Concerning DHFL, one can buy at Rs 520-525 levels, with a stop-loss below Rs 500 and a target of Rs 575-580.

Amar Singh: Watch out for the level of Rs 128. If the stock sustains above that level, there could be a rally and the investor could see some profits. If the investor wishes to hold, he should have a stop loss below Rs 119 and watch for an initial target of Rs 128.

Parthiv Shah: One can buy ITC at current levels with a time horizon of about two years. Instead of Aurobindo Pharma, I prefer Cadila Healthcare, because the product launch pipeline looks far more robust.

Parthiv Shah: I would suggest you to exit. In mid-cap IT, the investor should consider investing in Majesco, which is a stock that can give very good returns over the next three years.